Global Newcastle Disease Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2112250101 | Category: Pharma & Healthcare | Pages: 104 | Format: PDF | Published Date: October 17,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Newcastle Disease Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Newcastle Disease Vaccine market size is estimated to be worth US$ 323.9 million in 2021 and is forecast to a readjusted size of USD 402.7 million by 2028 with a CAGR of 3.2% during review period. Chicken accounting for % of the Newcastle Disease Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Live Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, and Yebio, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Newcastle Disease Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Live Vaccines
    Killed Vaccines
Market segment by Application can be divided into
    Chicken
    Duck & Goose
    Other
The key market players for global Newcastle Disease Vaccine market are listed below:
    Merial
    CEVA
    QYH Biotech
    Ringpu Biology
    Yebio
    Harbin Veterinary Research Institute
    Merck Animal Health
    DHN
    Zoetis
    ChengDu Tecbond
    Elanco (Lohmann)
    FATRO
    CAVAC
    Vaksindo
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Newcastle Disease Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Newcastle Disease Vaccine, with price, sales, revenue and global market share of Newcastle Disease Vaccine from 2019 to 2022.
Chapter 3, the Newcastle Disease Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Newcastle Disease Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Newcastle Disease Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Newcastle Disease Vaccine.
Chapter 13, 14, and 15, to describe Newcastle Disease Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Newcastle Disease Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Newcastle Disease Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Live Vaccines
        1.2.3 Killed Vaccines
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Newcastle Disease Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Chicken
        1.3.3 Duck & Goose
        1.3.4 Other
    1.4 Global Newcastle Disease Vaccine Market Size & Forecast
        1.4.1 Global Newcastle Disease Vaccine Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Newcastle Disease Vaccine Sales in Volume (2017-2028)
        1.4.3 Global Newcastle Disease Vaccine Price (2017-2028) 
    1.5 Global Newcastle Disease Vaccine Production Capacity Analysis
        1.5.1 Global Newcastle Disease Vaccine Total Production Capacity (2017-2028)
        1.5.2 Global Newcastle Disease Vaccine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Newcastle Disease Vaccine Market Drivers
        1.6.2 Newcastle Disease Vaccine Market Restraints
        1.6.3 Newcastle Disease Vaccine Trends Analysis
2 Manufacturers Profiles
    2.1 Merial
        2.1.1 Merial Details
        2.1.2 Merial Major Business
        2.1.3 Merial Newcastle Disease Vaccine Product and Services
        2.1.4 Merial Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 CEVA
        2.2.1 CEVA Details
        2.2.2 CEVA Major Business
        2.2.3 CEVA Newcastle Disease Vaccine Product and Services
        2.2.4 CEVA Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 QYH Biotech
        2.3.1 QYH Biotech Details
        2.3.2 QYH Biotech Major Business
        2.3.3 QYH Biotech Newcastle Disease Vaccine Product and Services
        2.3.4 QYH Biotech Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Ringpu Biology
        2.4.1 Ringpu Biology Details
        2.4.2 Ringpu Biology Major Business
        2.4.3 Ringpu Biology Newcastle Disease Vaccine Product and Services
        2.4.4 Ringpu Biology Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Yebio
        2.5.1 Yebio Details
        2.5.2 Yebio Major Business
        2.5.3 Yebio Newcastle Disease Vaccine Product and Services
        2.5.4 Yebio Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Harbin Veterinary Research Institute
        2.6.1 Harbin Veterinary Research Institute Details
        2.6.2 Harbin Veterinary Research Institute Major Business
        2.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
        2.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Merck Animal Health
        2.7.1 Merck Animal Health Details
        2.7.2 Merck Animal Health Major Business
        2.7.3 Merck Animal Health Newcastle Disease Vaccine Product and Services
        2.7.4 Merck Animal Health Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 DHN
        2.8.1 DHN Details
        2.8.2 DHN Major Business
        2.8.3 DHN Newcastle Disease Vaccine Product and Services
        2.8.4 DHN Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Zoetis
        2.9.1 Zoetis Details
        2.9.2 Zoetis Major Business
        2.9.3 Zoetis Newcastle Disease Vaccine Product and Services
        2.9.4 Zoetis Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 ChengDu Tecbond
        2.10.1 ChengDu Tecbond Details
        2.10.2 ChengDu Tecbond Major Business
        2.10.3 ChengDu Tecbond Newcastle Disease Vaccine Product and Services
        2.10.4 ChengDu Tecbond Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Elanco (Lohmann)
        2.11.1 Elanco (Lohmann) Details
        2.11.2 Elanco (Lohmann) Major Business
        2.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Product and Services
        2.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 FATRO
        2.12.1 FATRO Details
        2.12.2 FATRO Major Business
        2.12.3 FATRO Newcastle Disease Vaccine Product and Services
        2.12.4 FATRO Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 CAVAC
        2.13.1 CAVAC Details
        2.13.2 CAVAC Major Business
        2.13.3 CAVAC Newcastle Disease Vaccine Product and Services
        2.13.4 CAVAC Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 Vaksindo
        2.14.1 Vaksindo Details
        2.14.2 Vaksindo Major Business
        2.14.3 Vaksindo Newcastle Disease Vaccine Product and Services
        2.14.4 Vaksindo Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Newcastle Disease Vaccine Breakdown Data by Manufacturer
    3.1 Global Newcastle Disease Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Newcastle Disease Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Newcastle Disease Vaccine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Newcastle Disease Vaccine Manufacturer Market Share in 2021
        3.4.2 Top 6 Newcastle Disease Vaccine Manufacturer Market Share in 2021
    3.5 Global Newcastle Disease Vaccine Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Newcastle Disease Vaccine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Newcastle Disease Vaccine Market Size by Region
        4.1.1 Global Newcastle Disease Vaccine Sales in Volume by Region (2017-2028)
        4.1.2 Global Newcastle Disease Vaccine Revenue by Region (2017-2028)
    4.2 North America Newcastle Disease Vaccine Revenue (2017-2028)
    4.3 Europe Newcastle Disease Vaccine Revenue (2017-2028)
    4.4 Asia-Pacific Newcastle Disease Vaccine Revenue (2017-2028)
    4.5 South America Newcastle Disease Vaccine Revenue (2017-2028)
    4.6 Middle East and Africa Newcastle Disease Vaccine Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Newcastle Disease Vaccine Sales in Volume by Type (2017-2028)
    5.2 Global Newcastle Disease Vaccine Revenue by Type (2017-2028)
    5.3 Global Newcastle Disease Vaccine Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Newcastle Disease Vaccine Sales in Volume by Application (2017-2028)
    6.2 Global Newcastle Disease Vaccine Revenue by Application (2017-2028)
    6.3 Global Newcastle Disease Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Newcastle Disease Vaccine Sales by Type (2017-2028)
    7.2 North America Newcastle Disease Vaccine Sales by Application (2017-2028)
    7.3 North America Newcastle Disease Vaccine Market Size by Country
        7.3.1 North America Newcastle Disease Vaccine Sales in Volume by Country (2017-2028)
        7.3.2 North America Newcastle Disease Vaccine Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Newcastle Disease Vaccine Sales by Type (2017-2028)
    8.2 Europe Newcastle Disease Vaccine Sales by Application (2017-2028)
    8.3 Europe Newcastle Disease Vaccine Market Size by Country
        8.3.1 Europe Newcastle Disease Vaccine Sales in Volume by Country (2017-2028)
        8.3.2 Europe Newcastle Disease Vaccine Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Newcastle Disease Vaccine Sales by Type (2017-2028)
    9.2 Asia-Pacific Newcastle Disease Vaccine Sales by Application (2017-2028)
    9.3 Asia-Pacific Newcastle Disease Vaccine Market Size by Region
        9.3.1 Asia-Pacific Newcastle Disease Vaccine Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Newcastle Disease Vaccine Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Newcastle Disease Vaccine Sales by Type (2017-2028)
    10.2 South America Newcastle Disease Vaccine Sales by Application (2017-2028)
    10.3 South America Newcastle Disease Vaccine Market Size by Country
        10.3.1 South America Newcastle Disease Vaccine Sales in Volume by Country (2017-2028)
        10.3.2 South America Newcastle Disease Vaccine Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Newcastle Disease Vaccine Sales by Type (2017-2028)
    11.2 Middle East & Africa Newcastle Disease Vaccine Sales by Application (2017-2028)
    11.3 Middle East & Africa Newcastle Disease Vaccine Market Size by Country
        11.3.1 Middle East & Africa Newcastle Disease Vaccine Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Newcastle Disease Vaccine Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Newcastle Disease Vaccine and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Newcastle Disease Vaccine
    12.3 Newcastle Disease Vaccine Production Process
    12.4 Newcastle Disease Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Newcastle Disease Vaccine Typical Distributors
    13.3 Newcastle Disease Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Newcastle Disease Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?